Navigation Links
New criteria for measuring tumor size and progression will help ease workloads in clinical trials
Date:1/19/2009

The first, formal revision of specific guidelines, known as RECIST, used by clinicians to measure tumour size and response to treatment, has been published today (Tuesday 20 January) in a special issue of the European Journal of Cancer [1]. The authors say that the revisions will ease the workload involved in running clinical trials, without compromising study outcomes.

RECIST (Response Evaluation Criteria in Solid Tumours) were first published in 2000 and are used by investigators in phase II and phase III clinical trials of new anti-cancer drugs as a way of measuring the efficacy of the treatment. Tumour shrinkage (objective response) and time to the development of disease progression are both important endpoints in trials, and, increasingly in recent years, trials have been using time to progression (or progression-free survival) as their main endpoint on which to base conclusions about the efficacy of a drug.

The new RECIST (RECIST 1.1 to distinguish them from the original RECIST) answer some of the questions and issues that have arisen since 2000 as a result of changing methodologies and available treatments.

Professor Jaap Verweij (Erasmus University Medical Centre, The Netherlands), the EJC's clinical oncology editor and a co-editor of the special issue on RECIST, said: "This special issue is very important for the cancer community as the updated criteria will affect all clinicians who are running clinical cancer trials. RECIST 1.1 describes a standard approach to solid tumour measurement and definitions for objective assessment of change in tumour size for use in adult clinical trials."

Co-editor, Professor Elizabeth Eisenhauer (National Cancer Institute of Cancer, Ontario, Canada), stressed that the goal of developing RECIST 1.1 was to improve the consistency and standardisation of trials. "Drug development and clinical cancer research is a global enterprise. The more consistent we are in describing what we have seen
'/>"/>

Contact: Emma Mason (media enquiries only)
wordmason@mac.com
44-077-112-96986
ECCO-the European CanCer Organisation
Source:Eurekalert

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. New appropriate use criteria guide treatment of patients with heart blockage
2. Eligibility criteria contribute to racial disparities in hospice use
3. New Criteria Could Expand Number of Liver Transplant Candidates
4. How Patients Can Meet the Criteria for Insulin Pump Therapy
5. New Rhode Island Hospital study shows inadequate diagnostic criteria for eating disorders
6. Capital BlueCross CEO Says Meaningful Statewide Competition Must Be Key Criteria in Pennsylvanias Review of Proposed Highmark-IBC Merger
7. Landmark Articles Published by QualityMetric Scientists Report Improvements in Short Form Health Status Measures and Establish Criteria for Future Development
8. BMI criteria for obesity surgery should be lowered, UT Southwestern researchers suggest
9. Criteria Predict Womens 5-Year Risk for Fracture
10. New Test Criteria Spots Rheumatoid Arthritis Sooner
11. Health Care Leaders to Use New National Criteria for Patient-Centered Medical Home
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Philadelphia, Pa. (June 19, 2013) The results of ... issue of Neurosurgery , official journal of the ... is published by Lippincott Williams & Wilkins , ... One study indicates that continuous "machine learning" using artificial ... survival in patients with advanced brain cancers. Another study ...
(Date:6/19/2013)... In early April, senior leaders from medical, law ... to discuss one question: how can first responders improve ... The preliminary results of this discussion are now available ... Hartford Consensus ," a concept paper published in the ... Trauma and Acute Care Surgery , official publication ...
(Date:6/19/2013)... system for repairing damage to the genetic material DNA ... may seem, those compounds are sparking optimism as potential ... mutation in BRCA, a gene that made headlines when ... compounds, termed PARP inhibitors, are the topic of the ... & Engineering News . C&EN is the weekly news ...
(Date:6/19/2013)... Ariz. (PRWEB) June 19, 2013 PREFERRED ... WellCare of Arizona to offer a new ... Maricopa, Pima, La Paz, Yavapai and Mohave, Arizona counties. ... Mohave counties were effective January 1, 2013 and Maricopa ... 2014. , WellCare, Inc., the parent company of WellCare ...
(Date:6/19/2013)... Kansas City will host its first Ciclovia event ... . A section of Main Street in the midtown area will ... the event. The Main Street Corridor Development and ... Kansas City join the ranks of dozens of cities across the ... foster community vibrancy and active lifestyles. , “Ciclovia is the perfect ...
Breaking Medicine News(10 mins):Health News:Neurosurgery publishes findings of 3 important studies in June issue 2Health News:Neurosurgery publishes findings of 3 important studies in June issue 3Health News:Hartford consensus aims to improve survival after mass shootings 2Health News:PREFERRED Therapy Providers, Inc. and WellCare of Arizona Finalize Their Agreement to Offer Medicare Advantage Plan to PREFERRED's Arizona Provider Network 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3
... American Journal of Transplantation reveals that cigarette smoke ... would have been prevented by certain drug treatments. Led ... Health Science Center, researchers used mouse transplant models to investigate ... and its mechanism of action. Seven to eight mice ...
... has shown that removing polyps by colonoscopy not only prevents ... disease. Patients in the study were evaluated for up to ... results to date. The collaborative study, led by researchers at ... 23, 2012 issue of The New England Journal of ...
... WEDNESDAY, Feb. 22 (HealthDay News) --,Toddlers are more likely to ... quickly and overreact to their children,s behavior, according to a ... behavior of adopted children aged 9 months, 18 months and ... 10 states. Researchers also analyzed genetic data from the children ...
... found that insulin production may persist for decades after the ... appears to be preserved in some patients years after apparent ... March issue of Diabetes Care . ... in patients with advanced type 1 diabetes. However, data ...
... HealthDay Reporter , TUESDAY, Feb. 21 (HealthDay News) -- ... sensitivity, but a new analysis suggests that many people who ... Health experts have claimed that this special diet can ... a substance found in wheat, barley, rye and possibly oats. ...
... HealthDay Reporter , TUESDAY, Feb. 21 (HealthDay ... patients with blocked leg arteries, a new European study ... disease, often suffer from intermittent claudication, which is pain ... legs. Animal experiments had suggested that aspirin might block ...
Cached Medicine News:Health News:Colonoscopy prevents deaths from colon cancer 2Health News:Toddlers With Angry Parents May Have More Temper Tantrums 2Health News:Study finds some insulin production in long-term Type 1 diabetes 2Health News:Is Avoiding Gluten in Foods Always Necessary? 2Health News:Is Avoiding Gluten in Foods Always Necessary? 3Health News:Aspirin as Good as Plavix for Poor Leg Circulation: Study 2
(Date:6/19/2013)... -- The American Association for Homecare (AAHomecare), along with a ... announced today the filing of a lawsuit in ... asking that the scheduled July 1 expansion of the Medicare ... stopped because of serious licensing irregularities. The lawsuit ... Secretary Kathleen Sebelius as the defendant. HHS oversees ...
(Date:6/19/2013)... 19, 2013 Ellen MacArthur ... kommande tre åren kommer att vara en partner ... cirkulär ekonomi. Efter stiftelsens framgångsrika partnerskap ... Grid, kommer Philips att ansluta sig som partner ... i sin egen verksamhet och stödja stiftelsens arbete ...
(Date:6/19/2013)... , June 19, 2013  Finesse Solutions, Inc, ... life sciences process applications, announced the launch of ... upstream cell culture and fermentation.  The 3L glass ... family of Finesse bioreactors and are designed to ... They are fully compatible with all Finesse G3Lab ...
Breaking Medicine Technology:AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 2AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 3AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 4AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 5Ellen MacArthur Foundation presenterar Philips som global partner vid det konstituerande internationella toppmötet om cirkulär ekonomi 2Ellen MacArthur Foundation presenterar Philips som global partner vid det konstituerande internationella toppmötet om cirkulär ekonomi 3Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation 2
... 11, 2011 MedQuist Holdings Inc. (Nasdaq: ... of integrated clinical documentation solutions for the U.S. healthcare ... public offering of shares of its common stock.  The ... NASDAQ Global Market under the ticker symbol MEDH. ...
... Feb. 11, 2011 Vitalitec International, ... of the ENCLOSE II Anastomosis Assist Device from Novare ... was developed by Thomas Fogarty, MD, and is designed ... Bypass Procedures. Vitalitec International, Inc. is a ...
Cached Medicine Technology:MedQuist Holdings Inc. Announces Closing of Its Initial U.S. Public Offering and Acquisition of Additional Shares of MedQuist Inc. 2MedQuist Holdings Inc. Announces Closing of Its Initial U.S. Public Offering and Acquisition of Additional Shares of MedQuist Inc. 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: